USPTO serial 99363899
E
Reviewed by CopyMark Law Group
Status 748
- Filing date
- Status date
- Registration date
- —
- Examiner
- JACKSON, SHA-KARA ELOUISE
- Law office
- TMEG LAW OFFICE 101
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with E?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D Olszyk, Jr.
Christopher D Olszyk, Jr. Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded software for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Downloadable or recorded software for biometric data analytics; Downloadable or recorded software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; downloadable or recorded software for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Downloadable or recorded software for collection and analysis of eye-tracking, blink data and other human biometric data; downloadable or recorded software for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto; Scientific apparatus, namely, apparatus for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto, not for medical use | ACTIVE | May 4, 2026 |
| 010 | Medical device for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical device, namely, a device for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; medical device for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; medical device for collection and analysis of eye-tracking and blink data and other human biometric data; medical eye-tracking and blink-detection device for detecting autism spectrum and other neurodevelopmental or cognitive conditions and disorders | ACTIVE | May 4, 2026 |
| 042 | Platform as a service (PAAS) featuring computer software platforms for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Software as a service (SAAS) service featuring software for human biometric data management, data synchronization, data analytics, data automation, and data integration; Computer services, namely, providing data as a service (DaaS) featuring software for collecting, analyzing, integrating, transforming and providing access to human biometric data and information; Providing online non-downloadable software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Software as a service (SaaS) services featuring software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Platform as a service (PAAS) featuring computer software platforms for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Providing online non-downloadable software for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Providing online non-downloadable software for collection and analysis of eye-tracking, blink data, and other human biometric data; providing online non-downloadable software for displaying stimuli to users and collecting eye-movement, blink, and other human biometric data in response thereto; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for analyzing data and interacting with humans | ACTIVE | May 4, 2026 |
| 044 | Medical testing services for the purpose of enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical testing for diagnostic assessment, detecting and treatment in the field of autism spectrum and other neurodevelopmental conditions and disorders; Providing information in the field of autism spectrum and other neurodevelopmental conditions and disorders; Assessing, screening, monitoring, or diagnosing of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Collecting and analyzing eye-tracking and blink data for detection of autism spectrum and other neurodevelopmental conditions and disorders | ACTIVE | Oct 7, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Earlitec Diagnostics, Inc.
- Other trademarks owned by Earlitec Diagnostics, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named E
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 14, 2026 | IUAF | USE AMENDMENT FILED | — |
| Oct 14, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 14, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 24, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2026 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 28, 2025 | NWAP | NEW APPLICATION ENTERED | — |